Quimi Daphne

Average Profitability
74.63%
Insider Buys Quantity
4
Insider Buys Sum
$276,515.58
Insider Sells Quantity
21
Insider Sells Sum
$2.55M

Insider Activity of Quimi Daphne

According to the SEC Form 4 filings, Quimi Daphne, being in a position of

  1. director at Century Therapeutics, Inc.,
    оver the last 12 months, has bought 5000 shares for $7,657, and sold 0 shares,
    over all time since 2024-09-12, has bought 5000 shares for $7,657, and sold 0 shares.

The largest purchase of all time was on 2014-09-29 and amounted to 21476 shares of Amicus Therapeutics, Inc. for $130,931.

The largest sale of all time was on 2020-01-09 and amounted to 30000 shares of Amicus Therapeutics, Inc. for $297,903.

Biography of Quimi Daphne

No biography is available at this moment.

2024-09-12PurchaseCentury Therapeutics, Inc.
IPSC
director
5,000
0.0059%
$1.53$7,657+0.65%
2023-01-18SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
6,923
0.0024%
$13.00$89,999-6.74%
2023-01-17SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,000
0.0017%
$12.49$62,445-1.63%
2022-09-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
4,397
0.0015%
$11.29$49,621+2.9%
2022-08-05SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,798
0.002%
$12.00$69,576-3.2%
2022-06-17SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
4,396
0.0014%
$9.00$39,564+22.83%
2020-12-21SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,000
0.0019%
$24.09$120,474-56.42%
2020-10-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
5,000
0.0019%
$14.02$70,099-23.22%
2020-07-01SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
13,744
0.0053%
$15.47$212,651-6.85%
2020-01-09SaleAmicus Therapeutics, Inc.
FOLD
Chief Financial Officer
30,000
0.012%
$9.93$297,903+44.42%
2018-03-09SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
17,500
0.007%
$10.48$183,400-11.84%
2018-03-01SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
16,298
0.0059%
$9.11$148,436-6.9%
2018-01-02SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
16,000
0.0075%
$12.54$200,603-6%
2017-10-12SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
14,000
0.0075%
$12.23$171,210+1.4%
2016-11-09SaleAmicus Therapeutics, Inc.
FOLD
SVP, Finance
8,546
0.0035%
$8.00$68,368-3.86%
2015-10-01SaleAmicus Therapeutics, Inc.
FOLD
Vice President Finance
22,500
0.0102%
$7.79$175,323-48.55%
2015-09-14SaleAmicus Therapeutics, Inc.
FOLD
Vice President Finance
5,000
0.0042%
$18.08$90,400-60.89%
2015-07-01SaleAmicus Therapeutics, Inc.
FOLD
Vice President Finance
5,200
0.0044%
$13.98$72,700-43.01%
2015-05-11SaleAmicus Therapeutics, Inc.
FOLD
VP Finance and Controller
15,000
0.0151%
$10.84$162,612-10.41%
2014-11-25SaleAmicus Therapeutics, Inc.
FOLD
VP Finance and Controller
7,000
0.0072%
$6.08$42,560+35.35%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.